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Monitoring Acute Kidney Injury
Acute kidney injury lacks effective treatment, except for
supportive renal replacement therapy such as dialysis.
Novel biomarkers therefore need to be developed to
identify injury at early time points as well as to estimate
the severity of the damage. Negishi et al (Am J Pathol
2009, 174: 1154–1159) examined whether levels of uri-
nary L-type fatty acid-binding protein (L-FABP) could be
used to monitor acute kidney injury. Levels of L-FABP
correlated with the level of acute kidney injury at signifi-
cantly earlier time points than levels of conventional renal
markers such as blood urea nitrogen or urinary N-acetyl-
D-glucosaminidase. In addition, L-FABP showed better
correlation than blood urea nitrogen or N-acetyl-D-glu-
cosaminidase with final histological injury scores, espe-
cially at early time points. L-FABP thus represents a bet-
ter choice than conventional renal markers for evaluating
early acute kidney injury.
Unfolded Protein Response Is Activated in
Pretangle Neurons in Alzheimer’s Disease
The unfolded protein response protects cells from the
toxic effects of accumulated misfolded proteins; how-
ever, prolonged activation of the unfolded protein re-
sponse, such as in Alzheimer’s disease, may lead to cell
death. Hoozemans et al (Am J Pathol 2009, 174: 1241–
1251) hypothesized that the unfolded protein response
contributed to neurodegeneration in Alzheimer’s disease
partially through its effects on the accumulation of hyper-
phosphorylated tau, a major component of intracellular
neurofibrillary tangles in patients with Alzheimer’s dis-
ease. Unfolded protein response markers co-localized
with tau accumulation and expression of GSK-3, which
phosphorylates tau, in hippocampi from patients with
Alzheimer’s disease but not from control patients. Un-
folded protein response-related proteins were expressed
in pretangle hippocampal neurons but were absent in
tangle neurons. The unfolded protein response may, there-
fore, be pathogenic in neurodegeneration in Alzheimer’s
disease.
Bacterial Lymphostatin Disrupts Epithelial
Barrier Function
Enteric Gram-negative bacteria can breach the intestinal
epithelial barrier and cause systemic infection. Lympho-
statin, a toxin produced by Gram-negative bacteria in-
cluding enteropathogenic Escheria coli and Citrobacter
rodentium, has been associated with bacterial virulence.
To determine whether lymphostatin affects epithelial bar-
rier integrity, Babbin et al (Am J Pathol 2009, 174: 1347–
1357) generated strains of C. rodentium with mutations in
either the glucosyltransferase (CrGIM21) or protease
(CrPrM5) domain of lymphostatin. Whereas wild-type C.
rodentium disrupted epithelial barrier function, CrGIM21
and CrPrM5 had reduced effects on tight junctions and
adherens junctions, respectively. These effects were me-
diated through modulation of Rho-GTPase activities.
These data suggest that lymphostatin may be a strong
target candidate for treatment of enteric Gram-negative
bacteria.
NF-B Activation Tracking Detects Early
Autoimmunity
Early, preclinical, detection of autoimmunity is imperative
to assess new therapeutic strategies. Inflammatory re-
sponses activate NF-B, making it a prime candidate to
track autoimmune activity. Zangani et al (Am J Pathol
2009, 174: 1358–1367) used a bioluminescence reporter
system to label NF-B activation in a mouse model of
systemic autoimmunity with features of systemic lupus
erythematosus. They found that NF-B activation signals
were present in affected organs several weeks before
either autoantibody production or the clinical manifesta-
tions of disease. The bioluminescent signal intensity cor-
related with disease progression. NF-B tracking may
therefore provide a new tool in the evaluation of early
autoimmune therapies.
Mouse Model of Human Psoriasis
Psoriasis is a chronic inflammatory disease characterized
by epidermal hyperplasia, leukocyte infiltration, in-
creased angiogenesis, and increased presence of in-
flammatory cytokines. The study of psoriasis has been
limited, however, because of the absence of a mouse
model that adequately reproduces these symptoms.
Overexpression of the angiopoietin receptor Tie-2 in ep-
ithelial cells and keratinocytes has provided the best
psoriasis model to date. To determine whether Tie-2 over-
expression in epithelial cells or keratinocytes resulted in
the psoriasis phenotype, Wolfram et al (Am J Pathol
2009, 174: 1443–1458) engineered two new mouse mod-
els in which Tie-2 expression was limited to either epithe-
lial cells or keratinocytes. Only the keratinocyte-restricted
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Tie-2 mice developed a cutaneous psoriasiform pheno-
type, and the symptoms were reduced by either repres-
sion of the transgene or treatment with cyclosporin A, a
common psoriasis therapy. Keratinocyte-restricted Tie-2
mice, therefore, may serve as an animal model for human
psoriasis.
Galectin-3 Regulates Prostate Cancer
Progression
Down-regulation of galectin-3, a -galactosidase-binding
protein, has been reported to correlate with neoplastic
progression in prostate cancer; however, galectin-3 up-
regulation has also been linked to tumorigenicity in a
number of other tumor types. Wang et al (Am J Pathol
2009, 174: 1515–1523) examined the role of galectin-3
during prostate cancer progression. They found that ga-
lectin-3 was cleaved during prostate cancer progression.
In addition, galectin-3 siRNA knockdown led to reduced
cell migration, invasion, cell proliferation, anchorage-in-
dependent colony formation, and tumor growth in a
mouse model. In a human prostate cancer cell line, ga-
lectin-3 reduction was associated with metastatic events
such as reduced cell migration, cell invasion, and sup-
pression of matrix metalloproteinase-2 and -9. Thus,
cleaved galectin-3 may serve as a diagnostic marker and
therapeutic target for prostate cancer progression.
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